200 related articles for article (PubMed ID: 29849864)
1.
Benites J; Toledo H; Salas F; Guerrero A; Rios D; Valderrama JA; Calderon PB
Oxid Med Cell Longev; 2018; 2018():1618051. PubMed ID: 29849864
[TBL] [Abstract][Full Text] [Related]
2. A new anti-Helicobacter pylori juglone from Reynoutria japonica.
Khalil AAK; Park WS; Lee J; Kim HJ; Akter KM; Goo YM; Bae JY; Chun MS; Kim JH; Ahn MJ
Arch Pharm Res; 2019 Jun; 42(6):505-511. PubMed ID: 31073878
[TBL] [Abstract][Full Text] [Related]
3. A scoping review of African natural products against gastric ulcers and Helicobacter pylori.
Dinat S; Orchard A; Van Vuuren S
J Ethnopharmacol; 2023 Jan; 301():115698. PubMed ID: 36174808
[TBL] [Abstract][Full Text] [Related]
4. A review on the structures and biological activities of anti-Helicobacter pylori agents.
Ghobadi E; Ghanbarimasir Z; Emami S
Eur J Med Chem; 2021 Nov; 223():113669. PubMed ID: 34218084
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
[TBL] [Abstract][Full Text] [Related]
6. Medicinal plant activity on Helicobacter pylori related diseases.
Wang YC
World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-Helicobacter pylori activity of Syzygium aromaticum and the preliminary mechanism of action.
Peng C; Sang S; Shen X; Zhang W; Yan J; Chen P; Jiang C; Yuan Y; Zhu W; Yao M
J Ethnopharmacol; 2022 Apr; 288():114995. PubMed ID: 35032584
[TBL] [Abstract][Full Text] [Related]
8. Nontraditional therapies to treat Helicobacter pylori infection.
Makobongo MO; Gilbreath JJ; Merrell DS
J Microbiol; 2014 Apr; 52(4):259-72. PubMed ID: 24682990
[TBL] [Abstract][Full Text] [Related]
9. Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones.
Skouloubris S; Djaout K; Lamarre I; Lambry JC; Anger K; Briffotaux J; Liebl U; de Reuse H; Myllykallio H
Open Biol; 2015 Jun; 5(6):150015. PubMed ID: 26040760
[TBL] [Abstract][Full Text] [Related]
10. Quinone Derivatives as Promising Anti-
Xu M; Zhou J; Heng D; Su X; Onakpa MM; Bai Y; Duan JA; Che CT; Bi H; Zhao M
J Nat Prod; 2022 Apr; 85(4):1029-1038. PubMed ID: 35412828
[TBL] [Abstract][Full Text] [Related]
11. In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against
Spiegel M; Krzyżek P; Dworniczek E; Adamski R; Sroka Z
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011255
[No Abstract] [Full Text] [Related]
12. Helicobacter pylori drug resistance: therapy changes and challenges.
Flores-Treviño S; Mendoza-Olazarán S; Bocanegra-Ibarias P; Maldonado-Garza HJ; Garza-González E
Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):819-827. PubMed ID: 29976092
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.
Chen P; Chen M; Peng C; Yan J; Shen X; Zhang W; Yuan Y; Gan G; Luo X; Zhu W; Yao M
J Ethnopharmacol; 2024 Jan; 318(Pt B):116981. PubMed ID: 37574016
[TBL] [Abstract][Full Text] [Related]
14. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Helicobacter pylori infected mice with Bryophyllum pinnatum, a medicinal plant with antioxidant and antimicrobial properties, reduces bacterial load.
Kouitcheu Mabeku LB; Eyoum Bille B; Tchouangueu TF; Nguepi E; Leundji H
Pharm Biol; 2017 Dec; 55(1):603-610. PubMed ID: 27937097
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Helicobacter pylori Infection.
FitzGerald R; Smith SM
Methods Mol Biol; 2021; 2283():1-14. PubMed ID: 33765303
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol inhibits the growth of Helicobacter pylori in a manner distinct from antibiotics.
Yang R; Li J; Wang J; Wang Y; Ma F; Zhai R; Li P
J Food Biochem; 2022 Sep; 46(9):e14210. PubMed ID: 35484877
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori.
Shahin AI; Zaib S; Zaraei SO; Kedia RA; Anbar HS; Younas MT; Al-Tel TH; Khoder G; El-Gamal MI
PLoS One; 2023; 18(6):e0286684. PubMed ID: 37267378
[TBL] [Abstract][Full Text] [Related]
19. Infections with
Smith S; Fowora M; Pellicano R
World J Gastroenterol; 2019 Jul; 25(25):3183-3195. PubMed ID: 31333310
[No Abstract] [Full Text] [Related]
20. Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases.
Rostami H; Haddadi MH
Fundam Clin Pharmacol; 2022 Dec; 36(6):930-943. PubMed ID: 35716372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
